Home LiteratureArticle Details
PMID: 14576836 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Introduction to resistance to anticancer agents.

Oncogene ·Vol. 22 ·No. 47 ·2003-10-20 ·Pages 7262-4

Kruh GD

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/pharmacology,therapeutic use Apoptosis/drug effects Cell Division/drug effects Drug Delivery Systems Drug Resistance, Neoplasm Humans Neoplasms/drug therapy,genetics,pathology
Chemicals
Antineoplastic Agents
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kruh Gary D
Medical Science Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. [email protected]
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
DOI
10.1038/sj.onc.1206932
Email
[email protected]
Published
2003-10-20
Pages
7262-4
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · CA 06927 · United States
NCI NIH HHS · CA 73728 · United States
External Links
PubMed source DOI: 10.1038/sj.onc.1206932 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2